Yahoo
NYSE - Nasdaq Real Time Price USD

Novo Nordisk A/S (NVO)

40.00 +0.86 (+2.20%)
At close: October 30 at 4:00:02 PM EDT
39.97 -0.03 (-0.07%)
After hours: October 30 at 7:58:28 PM EDT
Trade NVO on Coinbase

News headlines

Updated 51m ago
Powered by Yahoo Scout

Novo Nordisk is positioning for tougher GLP-1 competition by expanding its obesity, diabetes, and liver-disease pipeline. Recent rival data from Eli Lilly strengthened concerns about product effectiveness, pricing pressure, and Novo’s reliance on semaglutide, while valuation models continue to show substantial potential upside.

Mobilize your Website
View Site in Mobile | Classic
Share by: